A recent study found that CovaShield is more effective when administered as a booster after two doses of Covaxin because the antibodies zoom in six-fold, however, as is the case when the vaccines are reversed. is not equal.
The study, presented by Christian Medical College, Vellore to the Drugs Controller General of India on Wednesday, is India’s first preliminary scientific evidence on combining COVID-19 vaccines. Scientists have estimated that Covaxin is less effective with two doses of Covashield as a booster, Indian Express Reported.
Quoting a source, In other words The report said the increase in antibodies is “relatively low” where Covaxin is administered on people who were already given two doses of CovaShield. However, data on neutralizing antibodies and T-cell response is expected next week.
National Technical Advisory Group on Immunization (NTAGI), advisory committee consisting of a multidisciplinary group of experts responsible for providing information to national governments, used to make evidence-based decisions regarding vaccines and vaccination policy , is expected to take a decision on the administration. Individual vaccines as a third dose based on final data from the study.
The government has opened up the precautionary dose to everyone over the age of 60 and children aged 12-17 to increase the vaccination numbers, urging all eligible people to get the shot.
In addition to Covishield and Covaxin, Biologicals-E’s long-awaited Corbevax vaccine has also joined the 12-14 age-group vaccination campaign. The government had given an advance of Rs 1,500 crore to Biological-E to reserve 30 crore vaccine doses for supply – this will be used to vaccinate children in the coming days. There is also a growing demand to open the precautionary regimen for all adults, which the government is considering and may take a decision in a few months after an investigation, an official said.
Union Health Minister Mansukh Mandaviya on Wednesday chaired a high-level meeting in view of the huge increase in the number of COVID-19 cases in China and Southeast Asia. Official sources told News18 that Mandaviya called for a high level of vigilance, aggressive genome sequencing and intensive monitoring. Sources said the meeting was attended by top health officials, including the Health Secretary, the Pharma Secretary and the Principal Scientific Adviser to the Government of India.
The meeting comes as China is witnessing a return of Covid-19 cases, led by the Omicron-led outbreak that reported 3,290 fresh infections in the country on Wednesday. China also tried to free up hospital beds as the highly permeable Omicron variant is posing a tough challenge to its zero-Covid strategy, resulting in the closure of 17.5 million residents of Shenzhen’s southern tech hub And other cities also have tighter restrictions.
read all breaking news , today’s fresh news And Ukraine-Russia War Live Updates Here.